Alan L. Hudson

9.2k total citations · 2 hit papers
146 papers, 7.4k citations indexed

About

Alan L. Hudson is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Alan L. Hudson has authored 146 papers receiving a total of 7.4k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 87 papers in Cellular and Molecular Neuroscience and 25 papers in Organic Chemistry. Recurrent topics in Alan L. Hudson's work include Receptor Mechanisms and Signaling (55 papers), Neuroscience and Neuropharmacology Research (43 papers) and Neurotransmitter Receptor Influence on Behavior (40 papers). Alan L. Hudson is often cited by papers focused on Receptor Mechanisms and Signaling (55 papers), Neuroscience and Neuropharmacology Research (43 papers) and Neurotransmitter Receptor Influence on Behavior (40 papers). Alan L. Hudson collaborates with scholars based in United Kingdom, Canada and United States. Alan L. Hudson's co-authors include Norman G. Bowery, David R. Hill, Geraint Price, Solomon Nwaka, David Nutt, Adam Doble, John S. Shaw, M J Turnbull, Derek N. Middlemiss and David Nutt and has published in prestigious journals such as Nature, Science and Nature Reviews Drug Discovery.

In The Last Decade

Alan L. Hudson

143 papers receiving 7.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

(–)Baclofen decreases neurotransmitter release in the mammalian CNS by an action at a novel GABA receptor

1980 891 citations Alan L. Hudson et al. profile →
GABAA and GABAB receptor site distribution in the rat central nervous system

1987 747 citations Alan L. Hudson et al. Neuroscience profile →

Peers

Alan L. Hudson

CMN

PHYSI

Charles R. Ashby United States

Kinzo Matsumoto Japan

Gabriel Nowak Poland

Jean A. Boutin France

Pier Luigi Canonico Italy

Michael F. Jarvis United States

Timothy W. Lovenberg United States

H. Steve White United States

Pekka T. Männistö Finland

Moshe Gavish Israel

Charles R. Ashby United States

Alan L. Hudson

3.8k ×0.9

CMN

5.3k ×1.6

679 ×0.7

509 ×0.5

PHYSI

742 ×1.3

Citations per year, relative to Alan L. Hudson Alan L. Hudson (= 1×) peers Charles R. Ashby

Countries citing papers authored by Alan L. Hudson

Since Specialization

Citations

This map shows the geographic impact of Alan L. Hudson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan L. Hudson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan L. Hudson more than expected).

Fields of papers citing papers by Alan L. Hudson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan L. Hudson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan L. Hudson. The network helps show where Alan L. Hudson may publish in the future.

Co-authorship network of co-authors of Alan L. Hudson

This figure shows the co-authorship network connecting the top 25 collaborators of Alan L. Hudson. A scholar is included among the top collaborators of Alan L. Hudson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan L. Hudson. Alan L. Hudson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sączewski, Jarosław, Alan L. Hudson, Mika Scheinin, et al.. (2016). Transfer of SAR information from hypotensive indazole to indole derivatives acting at α-adrenergic receptors: In vitro and in vivo studies. European Journal of Medicinal Chemistry. 115. 406–415. 10 indexed citations

Lalies, Maggie D., et al.. (2014). The modulatory action of harmane on serotonergic neurotransmission in rat brain. Brain Research. 1597. 57–64. 16 indexed citations

Silverstone, Peter H., Maggie D. Lalies, & Alan L. Hudson. (2012). Quetiapine and Buspirone Both Elevate Cortical Levels of Noradrenaline and Dopamine In vivo, but Do Not have Synergistic Effects. Frontiers in Psychiatry. 3. 82–82. 19 indexed citations

Sączewski, Franciszek, et al.. (2010). 3-[(Imidazolidin-2-yl)imino]indazole ligands with selectivity for the α2-adrenoceptor compared to the imidazoline I1 receptor. Bioorganic & Medicinal Chemistry. 19(1). 321–329. 19 indexed citations

Kornicka, Anita, Franciszek Sączewski, Jacek Petrusewicz, et al.. (2005). Synthesis and Biological Activities of Novel 1,2,3,5-Tetrahydroimidazo[2,1-b]quinazoline Derivatives.. Polish Journal of Chemistry. 79(1). 89–100. 1 indexed citations

Robinson, Emma, David Nutt, Helen C. Jackson, & Alan L. Hudson. (2005). The uptake of a fluorescently labelled antisense oligonucleotide in vitro and in vivo. Journal of Neuroscience Methods. 147(1). 48–54. 2 indexed citations

Sączewski, Franciszek, et al.. (2004). Synthesis of 2,3,5,6-tetrahydro-3H-imidazo[2,1-b] [1,3,5]benzotriazepines and their oxidative ring contraction into 1-(4,5-dihydro-1H-imidazol-2-yl)-1H-benzimidazoles. Il Farmaco. 60(2). 127–134. 3 indexed citations

Glennon, Richard A., et al.. (2004). Binding of β-carbolines at imidazoline I2 receptors: a structure–affinity investigation. Bioorganic & Medicinal Chemistry Letters. 14(4). 999–1002. 38 indexed citations

Robinson, Emma, et al.. (2003). Endogenous β‐Carbolines as Clonidine‐Displacing Substances. Annals of the New York Academy of Sciences. 1009(1). 157–166. 41 indexed citations

10.

Hudson, Alan L., et al.. (2003). Effects of the β-carbolines, harmane and pinoline, on insulin secretion from isolated human islets of Langerhans. European Journal of Pharmacology. 482(1-3). 189–196. 49 indexed citations

11.

Sączewski, Franciszek, et al.. (2003). 2-(4,5-Dihydro-1H-imidazol-2-yl)indazole (indazim) derivatives as selective I2 imidazoline receptor ligands. European Journal of Pharmaceutical Sciences. 20(2). 201–208. 29 indexed citations

12.

Robinson, Emma & Alan L. Hudson. (2000). [5] In vitro and in vivo effects of antisense on α2-adrenoceptor expression. Methods in enzymology on CD-ROM/Methods in enzymology. 314. 61–76. 6 indexed citations

13.

Hudson, Alan L.. (1999). Adult survivors of childhood sexual abuse as patients: Two case studies. Journal of Wound Ostomy and Continence Nursing. 26(2). 60–66. 3 indexed citations

14.

Eglen, Richard M., Alan L. Hudson, David A. Kendall, et al.. (1998). `Seeing through a glass darkly': casting light on imidazoline `I' sites. Trends in Pharmacological Sciences. 19(9). 381–390. 229 indexed citations

15.

Wikberg, Jarl E. S. & Alan L. Hudson. (1997). A series of novel imidazoline I2-receptor selective Schiff bases of 1-(benzylidenamino)-3,3-dimethylguanidine. Neurochemistry International. 30(1). 95–99. 2 indexed citations

16.

Lione, Lisa A., David Nutt, & Alan L. Hudson. (1996). [3H]2-(2-Benzofuranyl)-2-imidazoline: a new selective high affinity radioligand for the study of rabbit brain imidazoline I2 receptors. European Journal of Pharmacology. 304(1-3). 221–229. 45 indexed citations

17.

Reynolds, Gavin P., et al.. (1996). Imidazoline binding sites in Huntington's and Parkinson's disease putamen. European Journal of Pharmacology. 301(1-3). R19–R21. 40 indexed citations

18.

Hudson, Alan L., et al.. (1994). Localization of high affinity [3H]glibenclamide binding sites within the substantia nigra zona reticulata of the rat brain. Neuroscience. 61(2). 285–292. 27 indexed citations

19.

Glue, Paul, Jayne Bailey, Sue Wilson, Alan L. Hudson, & David Nutt. (1992). Thyrotropin-releasing hormone selectively reverses lorazepam-induced sedation but not slowing of saccadic eye movements.. Life Sciences. 50(6). PL25–PL30. 18 indexed citations

20.

Mallard, Nicholas, Alan L. Hudson, & David Nutt. (1992). Characterization and autoradiographical localization of non‐adrenoceptor idazoxan binding sites in the rat brain. British Journal of Pharmacology. 106(4). 1019–1027. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact